MRMC

Incognia Presents the Next-Generation Identity Signal for Preventing Promo Abuse and Combating Fraud at Two Premier Industry Events This Month

Retrieved on: 
Monday, May 6, 2024
Partner, Food, Conference, Tenderloin, San Francisco, Intelligence, Entrepreneurship, MRMC, Deepfake, Learning Technology Partners, SAN, Assurance

SAN JOSÉ, Calif., May 6, 2024 /PRNewswire-PRWeb/ -- Today, Incognia, the innovator in location identity solutions, announces it will be attending key industry events in May. The company will exhibit at Food on Demand on May 8-May 10 in Las Vegas and it will be one of the presenting sponsors of the Marketplace Risk Management Conference (MRMC) on May 14-16 in San Francisco.

Key Points: 
  • SAN JOSÉ, Calif., May 6, 2024 /PRNewswire-PRWeb/ -- Today, Incognia , the innovator in location identity solutions, announces it will be attending key industry events in May.
  • The online food delivery industry in the United States [generated approximately $287.5 billion, with approximately 44 million people reporting they used at least one food delivery app last year.
  • With that growing popularity comes the increase in bad actors and fraud committed on both the consumer and courier apps.
  • The session will discuss deepfakes, app cloners, emulators, virtualizers, image injection, and their impacts on fraud techniques such as fake accounts, voucher abuse, refund abuse, and identity fraud.

The Inner Circle acknowledges Mary J. Aloia-Dombrowski as a Pinnacle Professional Lifetime Member

Retrieved on: 
Monday, April 29, 2024
Education, Oncology, Critical care, Palliative care, JFK Medical Center, Terminal, Travel, Hospice, State university system, Mentorship, American Journal, Death, American Cancer Society, Parent, National Association, Clinical Social Work Journal, Friends, Master, Golf, Patient, MRMC, Pinnacle, Multimedia, Philosophy, Good, Stockton University, Inner circle, Journal, Muhlenberg Regional Medical Center, Nursing

PLAINFIELD, N.J., April 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary J. Aloia-Dombrowski is acknowledged as a Pinnacle Professional Lifetime Member for her contributions to Hospice Social Work.

Key Points: 
  • PLAINFIELD, N.J., April 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary J. Aloia-Dombrowski is acknowledged as a Pinnacle Professional Lifetime Member for her contributions to Hospice Social Work.
  • Ms. Aloia-Dombrowski is a highly respected hospice social worker currently working at Hackensack Meridian Health Hospice.
  • She enjoys reading the Journal of Social Work, Clinical Social Work Journal, and American Journal of Hospice and Palliative Medicine.
  • The most important days of your life are the day you were born and the day you figure out why."

Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information

Retrieved on: 
Thursday, April 25, 2024
Biometrics, Radiology, Biotechnology, Oncology, Health, Medical Devices, Health Technology, Clinical Trials, Contract research organization, European Investment Bank, FDA, EIB, United, Stand-alone, Traction, Partnership, BofA Securities, Cave rescue, Artificial intelligence, Growth, ChromeOS, MRMC, LCS, CSF, Bank statement, AUC, Cancer, CE

Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited) for the first quarter of 2024, as of March 31, 2024.

Key Points: 
  • Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited) for the first quarter of 2024, as of March 31, 2024.
  • The consolidated financial statements for the financial year ended December 31, 2023, were audited and approved by the Company’s Board of Directors on April 24, 2024.
  • In Quarter 1, our revenues were impacted by the postponement to Quarter 2 of some studies due to late patient recruitment.
  • Consistent with the long-lasting partnership between CSF and Median, this agreement strengthens the future relationship between CSF and Median.

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis

Retrieved on: 
Tuesday, April 16, 2024
Research, Medical Devices, Women, Clinical Trials, Biotechnology, Radiology, Consumer, Health, Science, Oncology, FDA, University, ROC, Cancer, Woman, Breast cancer, Breast disease, Tomosynthesis, MD, 3D, DBT, QTI, Patient, MRMC, AUC, Recall, Medical imaging

The study found that QTI’s Breast Acoustic CTTM is similarly effective as digital breast tomosynthesis (DBT), also known as 3D mammography, in that the area under receiver operating characteristic curve (AUC) was statistically non-inferior for QTI scan compared with DBT for the AUC difference margin of -0.05.

Key Points: 
  • The study found that QTI’s Breast Acoustic CTTM is similarly effective as digital breast tomosynthesis (DBT), also known as 3D mammography, in that the area under receiver operating characteristic curve (AUC) was statistically non-inferior for QTI scan compared with DBT for the AUC difference margin of -0.05.
  • This means that QTI technology is non-inferior to DBT in the detection of breast lesions as a whole, with high specificity in determining benign cysts and thus decreasing benign recall rates.
  • Unfortunately, routine screening mammograms are not recommended for women under 40 because risks outweigh potential benefits at this young age.
  • Fortunately, the now published results suggest that QTI’s technology can be a much-needed potential alternative to mammography for women too young to undergo mammography screening.

Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook

Retrieved on: 
Monday, January 29, 2024
Biometrics, Radiology, Biotechnology, Oncology, Health, Medical Devices, Health Technology, Clinical Trials, Mortality, ChromeOS, Bank statement, Lung cancer screening, HCC, Patient, Machine learning, Imaging, Artificial intelligence, REALITY, Partnership, Cave rescue, COVID-19, MRMC, Stand-alone, ESMO, AI, Lung cancer, Big Pharma, Growth, LCS, Hepatocellular carcinoma, Medical device, AUC, Acceleration, EIB, Small Business Saturday, Hospital, FDA, BofA Securities, Diagnosis, CE, European Investment Bank, Fine chemical

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.

Key Points: 
  • Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.
  • Fredrik Brag, Chief Executive Officer and Founder of Median Technologies, commented: "In Q4 2023, our iCRO1 business achieved record-high order intake, which increased significantly our backlog.
  • We expect to return to growth in 2024 on the back of a decline in 2023 revenue due to soft order intake in China caused by the Covid lockdowns in 2022 and H1 2023."
  • The Standalone study will be finalized in Q2 2024 and the MRMC study in Q3 2024.

Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD

Retrieved on: 
Monday, July 17, 2023
Health Technology, Other Health, Technology, Radiology, Oncology, Biometrics, Medical Devices, Hospitals, Clinical Trials, Science, Biotechnology, Software, Other Science, Health, Research, CE marking, Medical device, CT, MT, CMS, University, Brag, Centers for Medicare & Medicaid Services, Intervention, LCS, Journal of Thoracic Oncology, Cancer, Lung cancer, University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Lung, Pulmonology, MD Anderson Cancer Center, Medicare, MD, Lalit Vachani, Patient, Clinical research, MRMC, University of Pennsylvania Health System, Diagnosis, Hospital of the University of Pennsylvania, AI, Mortality, Hospital, FDA, Respiratory Medicine, Disease, Pharmaceutical industry, Medical imaging

For the purposes of its pivotal validation plan, Median Technologies has signed clinical research agreements with world-class academic healthcare institutions, which are leading healthcare centers for the management of lung cancer patients.

Key Points: 
  • For the purposes of its pivotal validation plan, Median Technologies has signed clinical research agreements with world-class academic healthcare institutions, which are leading healthcare centers for the management of lung cancer patients.
  • Median’s pivotal validation plan is composed of a pivotal standalone performance study (MT-LCS-002) and an international Multi-Reader Multi-Case (MRMC) pivotal clinical trial (MT-LCS-004).
  • Data quality is compulsory for the proper conduct of our pivotal validation plan” said Fredrik Brag, CEO and Founder of Median Technologies.
  • Now that we have onboarded all the sites, we are on track for the launch of our iBiopsy® LCS CADe/CADx SaMD pivotal validation plan.

Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan

Retrieved on: 
Wednesday, July 12, 2023
Data Management, Biotechnology, Technology, Other Health, Health, Biometrics, Oncology, Health Technology, Medical Devices, Software, Artificial Intelligence, Medical device, CE, Euronext Growth, US, EU, Cave rescue, LCS, Bank statement, BofA Securities, Clinical trial, Lung cancer screening, Fruit, Burn, European Investment Bank, Convertible, MRMC, CSF, EIB, FDA, Pharmaceutical industry, LP

Median Technologies (Euronext Growth - ALMDT) reports today its business indicators for the first half of 2023 for the iCRO activity (non-audited figures) and the iBiopsy® activity.

Key Points: 
  • Median Technologies (Euronext Growth - ALMDT) reports today its business indicators for the first half of 2023 for the iCRO activity (non-audited figures) and the iBiopsy® activity.
  • "When it comes to our iBiopsy® LCS CADe/CADx Software as Medical Device, the design of our pivotal validation plan has been finalized since March 2023.
  • In Q2 2023, the Company's revenue stands at €5.8M, up by 3.6% from Q1 2023 and 13.7% compared to Q4 2022 revenue.
  • As at June 30, 2023, Median Technologies' cash and cash equivalents stand at €8.3M, compared to €13.1M at March 31, 2023, i.e.

Lightbank and Craft Ventures-Backed SHOWRUNNER Wins Product Of The Year At NAB For Its Virtual Production Toolkit

Retrieved on: 
Thursday, April 20, 2023
National Association of Broadcasters, NAB, Samsung Galaxy Tab series, Partnership, IPad, Samsung, LED, National Association, Broadcaster, Software, Film industry, MRMC

LAS VEGAS, April 19, 2023 /PRNewswire/ -- One hundred years after the National Association of Broadcasters held its first annual convention, a one-year-old Chicago-based film technology company, SHOWRUNNER (https://showrunner.tech), won the prestigious Product Of The Year award for its software that makes Mandalorian-style virtual production easy and intuitive for filmmakers. While at NAB, the company also announced a global partnership with the virtual production studio network Vū.

Key Points: 
  • While at NAB, the company also announced a global partnership with the virtual production studio network Vū .
  • Virtual production is one of the fastest-growing trends in the film and TV industry.
  • Data from an industry survey SHOWRUNNER conducted in January on The State of Virtual Production showed that more than 70 percent of filmmakers predict they will do at least some virtual production work this year.
  • At the same time, many filmmakers also find virtual production to be technically difficult and complicated.

Milford Regional Medical Center Nurses Vote to Ratify First MNA Contract, Featuring Significant Investments in Nurses, and Strong Protections to Help Improve Patient Care Conditions

Retrieved on: 
Thursday, November 17, 2022
Legislature, Health, Workplace, BMC, Black scrub robin, Nursing, MP1, MNA, Physician, Negotiation, Caregiver, Commonwealth, Milford Regional Medical Center, Multimedia, Patient, COVID-19, Residential care, Medicine, MRMC

MILFORD, Mass., Nov. 17, 2022 /PRNewswire/ -- The more than 500 registered nurses of Milford Regional Medical Center, represented by the Massachusetts Nurses Association, voted overwhelmingly on November 16 to ratify their first collective bargaining agreement after unionizing in 2021 and working together to secure improvements to patient care, working conditions, wages, and benefits.

Key Points: 
  • "Milford Regional Medical Center nurses are amazing caregivers and have shown that working together gives us strength to overcome a global pandemic or any challenge thrown our way.
  • This contract values our dedication to patient care and will help us provide the conditions to recruit and retain the nurses we need."
  • "The result is a contract that Milford nurses were extremely proud to ratify and that will ultimately benefit everyone connected to our hospital."
  • The contract guarantees that charge nurses will be without a patient assignment or have a reduced patient assignment on in-patient units.

CarolinaEast Health System Ranked #3 in North Carolina on Newsweek's America's Best Physical Rehab Centers 2022 List

Retrieved on: 
Thursday, August 25, 2022
Patient safety, Joint Commission, Bed, Pain, Centers for Medicare & Medicaid Services, CarolinaEast Health System, News, Rehabilitation, MRMC, CMS, Master of Education, St. John's Rehab Hospital, PT, U.S. News & World Report, Center, Hospital, Medicare, KPI-driven code analysis, Certification, Industry, Life, IRF, Newsweek

NEW BERN, N.C., Aug. 25, 2022 /PRNewswire/ -- CarolinaEast Health System has been recognized on Newsweek's list of America's Best Physical Rehabilitation Centers 2022.

Key Points: 
  • NEW BERN, N.C., Aug. 25, 2022 /PRNewswire/ -- CarolinaEast Health System has been recognized on Newsweek's list of America's Best Physical Rehabilitation Centers 2022.
  • The 2022 list lands CarolinaEast Rehabilitation Hospital as #3 in North Carolina.
  • The America's Best Physical Rehabilitation Centers 2022 list highlights the nation's top inpatient rehabilitation facilities (IRFs) based on quality of care, quality of service, quality of follow-up care and accommodation and amenities.
  • It is an honor for CarolinaEast Rehab to receive this recognition," said Mitzi Holmes, MEd, PT, MRMC, Director of CarolinaEast Rehabilitation Hospital.